Melanoma
Results
Phase 2
This trial looked at a new drug called ranibizumab for a type of eye cancer called uveal melanoma.
Cancer Research UK supported this trial.
Recruitment start: 23 July 2012
Recruitment end: 17 October 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Heinrich Heimann
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Cancer Research Network: Cancer
Novartis
Royal Liverpool and Broadgreen University Hospital
The University of Liverpool Cancer Trials Unit
This is Cancer Research UK trial number CRUK/10/032.
Last reviewed: 9 August 2016
CRUK internal database number: 6187
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
